TrialThe Lancet. Oncology2023

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.

Shubham Pant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.